Skip to main content

FDA Approvals

FDA Approvals, In the News
FDA Approves Darzalex for Patients with Previously Treated Multiple Myeloma
Read More
FDA Approvals, In the News
FDA Approves Praxbind, the First Reversal Agent for the Anticoagulant Pradaxa
Read More
FDA Approvals
Vyvanse (Lisdexamfetamine Dimesylate): First FDA-Approved Drug for the Treatment of Adults with Binge-Eating Disorder
Read More
FDA Approvals
Ibrance (Palbociclib): First CDK4 and CDK6 Inhibitor FDA Approved for the Treatment of Postmenopausal Women with Metastatic Breast Cancer
Read More
FDA Approvals
Entresto (Sacubitril/Valsartan): First-in-Class Angiotensin Receptor Neprilysin Inhibitor FDA Approved for Patients with Heart Failure
Loretta Fala
Read More
FDA Approvals
Nivolumab Beats Docetaxel as Second-Line Therapy for Patients with NSCLC
Phoebe Starr
Read More
FDA Approvals
Oncology Pipeline Full, and Not Just with Immunotherapies
Caroline Helwick, Wayne Kuznar
Read More
FDA Approvals
FDA Update
Read More
FDA Approvals
CAR-T Cells: The Transplants of the Future
Chase Doyle
Read More
FDA Approvals
Encouraging Results for Pembrolizumab in Head and Neck Cancer
Phoebe Starr
Read More
Page 40 of 53
Results 391 - 400 of 528